Cytek® Biosciences, Inc. has announced the opening of a 50,000-square-foot facility in Wuxi, China to increase the company’s manufacturing capacity and meet the growing worldwide demand for comprehensive cell analysis solutions.
According to the company, the Wuxi facility offers the advantage of fostering unique vendor relationships and further facilitates Cytek to manufacture its own components, distinguishing the company from other industry players. In addition to bolstering Cytek’s manufacturing capabilities, the facility also accommodates Cytek Wuxi operations, research and development, marketing, human resources, and sales teams.
“The increasing application of cellular analysis in various fields, including immuno-oncology, infectious diseases and immunology, has led to a rising need for advanced cell analysis solutions – and we are taking a proactive approach to accommodate it,” said Wenbin Jiang, CEO of Cytek Biosciences. “Our roadmap has us continuing to expand our global footprint – and continuing to give scientists the tools and support they need to advance their research.”